NRP1 and COVID-19: There was no difference in the expression of ACE2, NRP1, and TMPRSS2 (SARS-CoV-2 receptors30) between BMMCs of HC (Supplementary Fig. S1k) and those of COVID-19 patients (Supplementary Fig. S1l–m).